Endonovo Therapeutics Inc (ENDV)

[Biotech_Tradez]

They have NO ABILITY to raise capital.

The company is debt-ridden thus the "spin-out" they are touting to rid themselves of the problem they created. Unfortunately, even if they spin out SofPulse, good luck raising money as an OTC penny stock.

That construction company deal is dead on arrival, expect it to be a footnote in one of the quarterly or annual reports.

This management team is not respected and thus will never be able to raise money from institutional investors.